| abstract |
The invention is directed to physiologically active compounds of general formula (Ix) (See formula Ix) and compositions containing these compounds, and their prodrugs, and pharmaceutically acceptable salts and solvates of these compounds and their prodrugs, as well as new compounds within the scope of the formula (Ix), and procedures for its preparation; These compounds and compositions have useful pharmaceutical properties, in particular the ability to inhibit kinases. |